三星生命公益基金会发现新型TLR信号通路抑制剂
Samsung Life Public Welfare Foundation discovers new TLR signaling inhibitors
生物技术与制药领域的最新动态
Samsung Life Public Welfare Foundation discovers new TLR signaling inhibitors
Otsuka’s IgAN therapy gets a thumbs-up from the FDA
Along with NIH cuts come risks to patient safety and scientific data
Illumina price attacks important resistance - Forecast today - 26-11-2025 - Economies.com
Sanofi headquarters raided in broader French tax fraud investigation
Will Waters Corporation (WAZ) stock rise with strong economy - Weekly Trade Summary & High Accuracy Buy Signal Tips - BỘ NỘI VỤ
How 10x Genomics Inc. stock responds to policy changes - 2025 Volatility Report & Risk Managed Trade Strategies - BỘ NỘI VỤ
Invitation to Roche’s Virtual Oncology/SABCS Investor Event - Roche
Kallyope scraps one of two mid-stage migraine drugs
Morgan Stanley upgrades Lonza Group stock to Overweight on growth outlook - Investing.com Australia
Thermo Fisher Scientific Stock: Is TMO Outperforming the Health Care Sector? - Barchart.com
Thermo Fisher Scientific Stock: Is TMO Outperforming the Health Care Sector? - Yahoo Finance
Orlando Roche: First Horizon Bank’s market president will extend his reach - Miami Today
Orlando Roche: First Horizon Bank’s market president will extend his reach - Miami Today
Holding the Line in Pokrovsk - The Dispatch
Agilent Technologies Stock Surges 9.3%, With A 5-Day Winning Spree - Trefis
Ammonia leak at Yakima's Roche Fruit prompts evacuations - Nonstop Local News
Otsuka’s anti-APRIL antibody gets FDA approval for kidney disease IgAN
Lawmakers probe FDA's new priority voucher program, cite corruption and rushed review concerns
GE HealthCare presents photon-counting CT system for FDA review